On Friday, October 27, there was the second webinar in a series with Dr. Carl Dieffenbach, the Director of the Division of AIDS (DAIDS) at the NIH’s National Institute of Allergy and Infectious Diseases, about the future of investments in the US National Institutes of Health’s (NIH) HIV clinical trial research networks in the US and internationally. A recording of the first webinar is available here.
As background, every seven years, the NIH reviews the structure and funding of its HIV clinical research networks. This “network recompetition” process involves decisions that will help determine the focus and priorities of its HIV clinical trial networks through 2027, as well as the number and structures of the various networks that undertake this research. These are critical questions for advocates to weigh in on—whether you are in the US or not. Learn more with our factsheet.
The webinar included a brief introductory presentation from Dr. Carl Dieffenbach followed by a Q&A session. NIAID is also accepting public comments and questions online until November 30, 2017, so now is your chance!
Recording: YouTube / Audio / Slides